SignalChem Lifesciences Corporation

$600,000.00 CAD

≈ 8 Canadians' average pay for a year
Department
National Research Council Canada
Program
Eureka/Eurostar
Recipient country
Canada
Fiscal year
2020-2021
Agreement period
August 17, 2020 – August 31, 2021
Reference
nrc-cnrc:172-2020-2021-Q2-956312

Published purpose

EUREKA Project 15211 EHAV-19 - Engineering of high affinity ACE2 variants as a treatment for Covid-19 with Austrian partner Innophore GmbH.

Community tags

Tags are applied by readers, not by this site. One tag per person per record.

Good value Local impact Needs context Questionable Success story Wasteful
View official source record Imported July 30, 2026 from open.canada.ca Grants & Contributions